15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 24.5% per year over the past 5 years.
Net income has grown faster than revenue (105.2% vs 24.5% per year).
Operating margin has expanded, at 17.5% in the latest year.
Financial health
Total debt has grown slower than revenue (19.9% vs 24.5% per year).
Operating income covered interest expense 8.0× in the latest year.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$2.7B
$247M
71.6%
17.5%
16.3%
7.7%
$378M
—
$716M
2024
$2.1B
$418M
69.8%
14.9%
34.5%
13.5%
$305M
—
$953M
2023
$1.7B
$206M
68.3%
13.0%
28.2%
8.0%
$70M
—
$704M
2022
$1.3B
$5M
61.7%
2.9%
1.0%
0.2%
-$4M
$1.4B
$690M
2021
$1.1B
$17M
68.4%
11.5%
3.0%
0.8%
-$180M
$1.3B
$806M
2020
$904M
$7M
64.4%
5.7%
1.1%
0.4%
-$45M
$1.1B
$922M
2019
—
$12M
—
—
15.3%
1.0%
-$65M
$888M
$214M
2018
—
$3M
—
—
1.6%
0.4%
-$122M
$592M
$114M
2017
$464M
-$27M
59.8%
-1.6%
-16.9%
-3.3%
-$33M
$566M
$273M
2016
$367M
-$29M
57.5%
-2.9%
-45.8%
-6.3%
-$6M
$333M
$137M
2015
$264M
-$74M
50.5%
-18.5%
-215.9%
-26.7%
-$23M
$172M
$123M
2014
$231M
-$52M
55.0%
-3.8%
-61.4%
-17.3%
-$3M
$164M
$151M
2013
—
-$45M
—
—
-36.1%
-15.6%
-$4M
$114M
—
2012
—
-$52M
—
—
-117.4%
-26.2%
-$40M
$118M
—
2011
—
-$46M
—
—
-55.4%
-20.7%
-$37M
$109M
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$802M
$95M
70.2%
16.2%
6.7%
3.0%
$56M
—
$535M
Mar '26
$762M
$91M
69.5%
16.0%
7.0%
3.0%
$90M
—
$480M
Dec '25
$784M
$102M
72.5%
18.7%
6.7%
3.2%
$48M
—
$716M
Sep '25
$706M
$88M
72.2%
16.7%
6.3%
2.9%
$100M
—
$757M
Jun '25
$649M
$23M
69.7%
18.7%
1.5%
0.6%
$178M
—
$1.1B
Mar '25
$569M
$35M
71.9%
15.6%
2.7%
1.0%
$52M
—
$1.3B
Dec '24
$598M
$101M
72.1%
18.3%
8.3%
3.3%
$94M
—
$953M
Sep '24
$544M
$78M
69.3%
16.2%
6.9%
2.6%
$82M
—
$903M
Jun '24
$489M
$189M
67.7%
11.2%
18.9%
6.5%
$64M
—
$821M
Mar '24
$442M
$52M
69.5%
12.9%
6.5%
2.0%
$66M
—
$751M
Dec '23
$510M
$103M
70.9%
20.9%
14.1%
4.0%
$16M
—
$704M
Sep '23
$433M
$52M
67.8%
12.7%
8.5%
2.1%
$36M
—
$685M
Jun '23
$397M
$27M
66.8%
7.8%
4.9%
1.1%
$28M
$1.4B
$660M
Mar '23
$358M
$24M
67.2%
7.7%
4.7%
1.0%
-$10M
$1.4B
$636M
Dec '22
$370M
$17M
58.8%
6.4%
3.6%
0.8%
-$14M
$1.4B
$690M
Sep '22
$341M
-$5M
55.3%
0.9%
-1.2%
-0.2%
$26M
$1.4B
$737M
Jun '22
$299M
-$35M
63.6%
-8.9%
-8.3%
-1.7%
$11M
$1.4B
$724M
Mar '22
$295M
$28M
71.0%
12.8%
6.2%
1.3%
-$27M
$1.4B
$725M
Dec '21
$308M
$29M
69.3%
16.2%
5.2%
1.4%
-$57M
$1.3B
$806M
Sep '21
$276M
$13M
68.5%
12.2%
2.5%
0.6%
-$53M
$1.3B
$871M
Valuation over time
How the market has priced PODD against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 4809.3× (Mar '23) to 43.1× (Nov '26).
The price-to-sales ratio has fallen from 16.9× (Mar '23) to 3.9× (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is PODD growing its revenue and profit?
Over the past 5 years, Insulet Corporation's revenue has grown 24.5% per year, and net income grown 105.2% per year. These are computed facts, not advice.
How much debt does PODD have?
As of FY2025, Insulet Corporation reported — of total debt against $716M of cash; operating income covered interest expense 8.0×.
What is PODD's profit margin?
In FY2025, gross margin was 71.6%, operating margin 17.5%, and net margin 9.1%.
What is PODD's P/E ratio?
Insulet Corporation's P/E (TTM) is 28.39 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the PODD stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 43.1× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.